Top

Journal of Cancer Research and Clinical Oncology

Published in:

01-10-2009 | Review

A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment

Authors: Loredana G. Marcu, E. Yeoh

Published in: Journal of Cancer Research and Clinical Oncology | Issue 10/2009

Abstract

Head and neck cancer is the fifth most common cancer worldwide but the most common malignant disease site in central Asia. The treatment of head and neck cancer is one of the most challenging in clinical oncology because of the high content of hypoxic cells of the cancer which increases resistance to therapy and also because of the high capacity of the cancer to regrow during treatment. For unresectable tumours, radiotherapy and chemotherapy alone or more often in combination is the treatment of choice. The aim of this paper is to review current understanding of carcinogenesis of head and neck cancer in relation to predisposing risk factors in general and for specific sub-sites and how these risk factors interact with the main reported genetic alterations in the progression of the cancer. The implications of these changes in determining choice of therapy are also discussed from a brief historical perspective of the various treatment approaches of head and neck cancer.

Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P et al (2003) The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol 16:944–950. doi:10.1097/01.MP.0000085760.74313.DD CrossRefPubMed

Al-Sarraf M, Pajak T, Marcial V et al (1987) Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG study. Cancer 59:259–265. doi:10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO;2-1 CrossRefPubMed

Arias F, Dominguez M, Illarramendi J et al (1995) Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report. Int J Radiat Oncol Biol Phys 33:675–682. doi:10.1016/0360-3016(95)00210-P PubMed

Bailet JW, Abemayor E, Jabour BA, Hawkins RA et al (1992) Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281–288PubMed

Beckmann GK, Hoppe F, Pfreundner L, Flentje MP (2005) Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck 27:36–43. doi:10.1002/hed.20111 CrossRefPubMed

Bedi GC, Westra WH, Gabrielson E et al (1996) Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56:2484–2487PubMed

Berrino F, Richiardi L, Boffetta P, Esteve J et al (2003) Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control 14:213–223. doi:10.1023/A:1023661206177 CrossRefPubMed

Bonner JA, Harari PM, Giralt J, Azarnia N et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567–578. doi:10.1056/NEJMoa053422 CrossRefPubMed

Brizel DM (1998) Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol 8:237–246. doi:10.1016/S1053-4296(98)80021-0 CrossRefPubMed

Browman G, Hodson I, Mackenzie R, Bestic N, Zuraw L (2001) Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis. Head Neck 20:579–589. doi:10.1002/hed.1081 CrossRef

Califano J, van der RP, Westra W et al (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56:2488–2492

Caplan LS, Hall HI, Levine RS, Zhu K et al (2000) Preventable risk factors for nasal cancer. Ann Epidemiol 10:186–191. doi:10.1016/S1047-2797(99)00049-6 CrossRefPubMed

Chen AM, Bucci MK, Quivey JM, Garcia J et al (2006) Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys 66:1044–1050. doi:10.1016/j.ijrobp.2006.06.050 PubMed

Closmann JJ (2007) The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know. Gen Dent 55(3):252–254PubMed

Creagan E, O’Fallon J, Woods J et al (1983) Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer. Cancer 51:2020–2023. doi:10.1002/1097-0142(19830601)51:11<2020::AID-CNCR2820511110>3.0.CO;2-X CrossRefPubMed

Douglas JG, Laramore GE, Austin-Seymour M, Koh WJ et al (1996) Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands. Int J Radiat Oncol Biol Phys 36:87–93. doi:10.1016/S0360-3016(96)00213-1 PubMed

Fan KF, Hopper C, Speight PM, Buonaccorsi G et al (1996) Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 78:1374–1383. doi:10.1002/(SICI)1097-0142(19961001)78:7<1374::AID-CNCR2>3.0.CO;2-L CrossRefPubMed

Feron VJ, Arts JH, Kuper CF, Slootweg PJ et al (2001) Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol 31:313–347. doi:10.1080/20014091111712 CrossRefPubMed

Fisch U (1983) The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope 93:36–44PubMed

Fisch U, Fagan P, Valvanis A (1984) The infratemporal fossa approach for the lateral skull base. Otolaryngol Clin North Am 17:513–552PubMed

Fontanesi J, Beckford NS, Lester EP et al (1991) Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck. Am J Surg 162:393–396. doi:10.1016/0002-9610(91)90156-8 CrossRefPubMed

Fu KK (1998) Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol 8:247–253. doi:10.1016/S1053-4296(98)80022-2 CrossRefPubMed

Gallicchio L, Matanoski G, Tao XG, Chen L et al (2006) Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer 119:1125–1135. doi:10.1002/ijc.21946 CrossRefPubMed

Garden AS, Harris J, Trotti A, Jones CU et al (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99–14). Int J Radiat Oncol Biol Phys 71:1351–1355. doi:10.1016/j.ijrobp.2008.04.006 PubMed

Gasparini G, Pozza F, Recher G et al (1991) Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck. Oncology 48:270–276CrossRefPubMed

Gleich L, Ryzenman J, Gluckman J, Wilson K et al (2004) Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg 130:35–38. doi:10.1001/archotol.130.1.35 CrossRefPubMed

Go SR, Adjei AA (1999) Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17(1):409–422PubMed

Grant WE, Hopper C, Speight PM, Macrobert AJ et al (1993) Photodynamic therapy of malignant and premalignant lesions in patients with ‘field cancerization’ of the oral cavity. J Laryngol Otol 107:1140–1145. doi:10.1017/S0022215100125496 CrossRefPubMed

Greven KM, Williams DW, Keyes JW Jr, McGuirt WF et al (1994) Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74:1355–1359. doi:10.1002/1097-0142(19940815)74:4<1355::AID-CNCR2820740428>3.0.CO;2-I CrossRefPubMed

Han D, Huang ZG, Zhang W, Yu ZK et al (2003) Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up. Chin J Cancer Res 83:2029–2032

Hardisson D (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260:502–508. doi:10.1007/s00405-003-0581-3 CrossRefPubMed

Herrero R, Castellsague X, Plissowska J et al (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95:1772–1783PubMed

Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE et al (2007) Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting—the MSKCC experience. Int J Radiat Oncol Biol Phys 67:691–702. doi:10.1016/j.ijrobp.2006.09.023 PubMed

Jacobs C, Bertino JR, Goffinet DR et al (1978) 24-hour infusion of cis-platinum in head and neck cancers. Cancer 42:2135–2140. doi:10.1002/1097-0142(197811)42:5<2135::AID-CNCR2820420508>3.0.CO;2-W CrossRefPubMed

Jeremic B, Shibamoto Y, Milicic B et al (2000) Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18:1458–1464PubMed

Julieron M, Temam S (2004) Locoregional recurrence of ORL cancer: the place of surgery. Bull Cancer 91:863–869PubMed

Kalyankrishna GJ (2006) Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 17:2666–2672. doi:10.1200/JCO.2005.04.8306 CrossRef

Kato K, Hara A, Kuno T, Mori H et al (2006) Aberrant promoter hypermethylation in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol 132:735–743. doi:10.1007/s00432-006-0122-8 CrossRefPubMed

Katz TS, Mendenhall WM, Morris CG, Amdur RJ et al (2002) Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck 24:821–829. doi:10.1002/hed.10143 CrossRefPubMed

Kawashiri S, Noguchi N, Tanaka A, Nakaya H et al (2009) Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model. Oral Oncol

Kim AJ, Suh JD, Sercarz JA, Abemayor E et al (2007) Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 117:1019:23

Kvaal SI, Warloe T (2007) Photodynamic treatment of oral lesions. J Environ Pathol Toxicol Oncol 26:127–133PubMed

Lawrence TS, Blackstock AW, McGinn C (2003) The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13(1):13–21. doi:10.1053/srao.2003.50002 CrossRefPubMed

Leipzig B (1983) Cisplatin sensitization to radiotherapy of squamous cell carcinomas of the head and neck. Am J Surg 146:462–465. doi:10.1016/0002-9610(83)90231-3 CrossRefPubMed

Lewin F, Norell SE, Johansson H, Gustavsson P et al (1998) Smoking tobacco, oral snuff, and alcohol in the aetiology of squamous cell carcinoma of the head and neck. Cancer 82:1367–1375. doi:10.1002/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3 CrossRefPubMed

Lonn S, Ahlbom A, Christensen HC, Johansen C et al (2006) Mobile phone use and risk of parotid gland tumor. Am J Epidemiol 164:637–643. doi:10.1093/aje/kwj242 CrossRefPubMed

Majem M, Mesia R, Mañós M, Gomez J et al (2006) Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d’Oncologia in stage III larynx carcinoma. Laryngoscope 116:1651–1656. doi:10.1097/01.mlg.0000231736.08477.47 CrossRefPubMed

Marchand JL, Luce D, Leclerc A, Goldberg P et al (2000) Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: results of a case-control study. Am J Ind Med 37:581–589. doi:10.1002/(SICI)1097-0274(200006)37:6<581::AID-AJIM2>3.0.CO;2-D CrossRefPubMed

Marcu L, van Doorn T, Olver I (2003) Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer. Acta Oncol 42(4):315–325. doi:10.1080/02841860310004364 CrossRefPubMed

Medina JA, Rueda A, de Pasos AS, Contreras J et al (2006) A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol 79:34–38. doi:10.1016/j.radonc.2006.03.010 CrossRefPubMed

Menvielle G, Luce D, Goldberg P, Bugel I et al (2004) Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case–control study in France. Eur J Cancer Prev 13:165–172. doi:10.1097/01.cej.0000130017.93310.76

Milas L, Mason K, Liao Z, Ang K (2003) Chemoradiotherapy: emerging treatment improvement strategie. Head Neck 25:152–167. doi:10.1002/hed.10232 CrossRefPubMed

Mould R (1993) A century of X-rays and radioactivity in medicine. Institute of Physics Publishing, Bristol

Nauta JM, van Leengoed HL, Star WM, Roodenburg JL et al (1996) Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. Eur J Oral Sci 104:69–81. doi:10.1111/j.1600-0722.1996.tb00049.x

Novacek G (2006) Plummer–Vinson syndrome. Orphanet J Rare Dis 15:1–36

Nylander K, Dabelsteen E, Hall PA (2000) The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med 29:413–425. doi:10.1034/j.1600-0714.2000.290901.x CrossRefPubMed

Olshan A, Weissler M, Pei H, Conway K (1997) p53 Mutations in head and neck cancer: new data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev 6:499–504PubMed

Overgaard J, Hansen HS, Specht L, Overgaard M et al (2003) Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362:933–940. doi:10.1016/S0140-6736(03)14361-9 CrossRefPubMed

Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P (2006) The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technol Assess 10:1–204

Perea-Milla L, Minarro-Del Moral RM, Martinez-Garcia C, Zanetti R et al (2003) Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer 88:1702–1707. doi:10.1038/sj.bjc.6600975 CrossRef

Perez-Ordoňez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59:445–453. doi:10.1136/jcp.2003.007641 CrossRefPubMed

Peters LJ, Withers HR (1997) Applying radiobiological principles to combined modality treatment of head and neck cancer—the time factor. Int J Radiat Oncol Biol Phys 39:831–836. doi:10.1016/S0360-3016(97)00466-5 PubMed

Robbins KT, Kumar P, Regine W et al (1997) Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 38:263–271. doi:10.1016/S0360-3016(97)00092-8 PubMed

Rosenquist K (2005) Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl 179:1–66PubMed

Sako K, Razack MS, Kalnins I (1978) Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum. Am J Surg 136:529–533. doi:10.1016/0002-9610(78)90276-3 CrossRefPubMed

Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H et al (2000) Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 60:892–895PubMed

Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S (1998) Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res 18:4779–4786PubMed

Schantz SP, Huang Q, Shah K, Murty VV et al (2000) Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers. Carcinogenesis 21:1239–1246. doi:10.1093/carcin/21.6.1239 CrossRefPubMed

Scher R, Esclamado R (2009) Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. Semin Radiat Oncol 19:17–23. doi:10.1016/j.semradonc.2008.09.004 CrossRefPubMed

Schuller DE, Ozer E, Agrawal A, Grecula JC et al (2007) Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience. Arch Otolaryngol Head Neck Surg 133:320–326. doi:10.1001/archotol.133.4.320 CrossRefPubMed

Seifert E, Schadel A, Haberkorn U, Strauss LG (1992) Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan). Head Neck Oncol 40:90–93

Serin M, Erkal HS, Cakmak A (1999) Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas. Acta Oncol 38:1031–1035. doi:10.1080/028418699432310 CrossRefPubMed

Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D et al (2006) Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol 164:367–375. doi:10.1093/aje/kwj208 CrossRefPubMed

Shirinian MH, Weber RS, Lippman SM, Dimery IW et al (1994) Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck 16:39–44. doi:10.1002/hed.2880160109

Slaughter DP, Southwick HW (1953) “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6:963–968. doi:10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q

Sturgis EM, Moore BA, Glisson BS, Kies MS et al (2005) Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series. Head Neck 27:748–756. doi:10.1002/hed.20240 CrossRefPubMed

Vikram B, Strong EW, Shah JP et al (1984) Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:730–733. doi:10.1002/hed.2890060305 CrossRefPubMed

Vivek RS, Baludavid M, Mohanram R, Chitra et al (2006) Concurrent chemo-irradiation using accelerated concomitant boost radiation therapy in loco-regionally advanced head and neck squamous cell carcinomas. J Cancer Res Ther 2:90–96

Wang Q, Wu Z, Han D, Zhang W et al (1999) Growth inhibition of human laryngeal cancer cell with the adenovirus-mediated p53 gene. Chin J Cancer Res 11:157–160CrossRef

Yoshikawa A, Saura R, Matsubara T (1997) A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization. Kobe J Med Sci 43:109–120PubMed

Young LS, Dawson CW, Clark D, Rupani H et al (1988) Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051–1065. doi:10.1099/0022-1317-69-5-1051 CrossRefPubMed

Youssef E, Lotan D, Issa JP, Wakasa K et al (2004) Hypermethylation of the retinoic acid receptor-ß₂ gene in head and neck carcinogenesis. Clin Cancer Res 10:1733–1742. doi:10.1158/1078-0432.CCR-0989-3 CrossRefPubMed

Yuan JM, Wang XL, Xiang YB, Gao YT et al (2000) Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 85:358–363. doi:10.1002/(SICI)1097-0215(20000201)85:3<358::AID-IJC11>3.0.CO;2-E CrossRefPubMed

Yuen W, Man M, Lam K, Kwong Y (2002) Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol 55:58–60CrossRefPubMed

Title: A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment
Authors: Loredana G. Marcu
E. Yeoh
Publication date: 01-10-2009
Publisher: Springer-Verlag
Published in: Journal of Cancer Research and Clinical Oncology / Issue 10/2009
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-009-0648-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2009

Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

RETRACTED ARTICLE: Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage